Australia markets closed

ABBV Jan 2024 55.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.17000.0000 (0.00%)
At close: 01:15PM EDT
Full screen
Previous close0.1700
Open0.1700
Bid0.0200
Ask0.3700
Strike55.00
Expiry date2024-01-19
Day's range0.1700 - 0.1700
Contract rangeN/A
Volume4
Open interest246
  • Motley Fool

    Better Buy: AbbVie vs. Johnson & Johnson

    AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.

  • Zacks

    Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL

    Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951

  • Motley Fool

    2 High-Yield Dividend Stocks You Won't Regret Buying Right Now

    High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.